+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 76Years
All Genders
ID06197308

Pilot Study of Oral Microbiota Therapy to Treat Primary Sclerosing Cholangitis in Adults Ages 18 to 76

Led by University of Minnesota · Updated on 2026-05-20

28

Participants Needed

1

Research Sites

22 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the initial safety and feasibility of microbiota transplant therapy MTT in patients with primary sclerosing cholangitis PSC, a liver disease. This early-phase pilot trial aims to gather information that will help design future studies for treating PSC. The study is sponsored by the University of Minnesota and focuses on exploring this new treatment approach. Participants will receive an antibiotic preconditioning regimen consisting of oral vancomycin 500 mg liquid twice daily for 28 days and oral amoxicillin 1000 mg twice daily for 7 days overlapping with the last week of vancomycin. Following this, a freeze-dried microbiota preparation MTP-101C is given orally as capsules, with five capsules daily for 3 days, then two capsules daily for 11 days, totaling 14 days of treatment and 37 capsules overall. During the trial, participants will be monitored for safety and how well they tolerate the therapy over 221 days. Researchers will assess outcomes such as adverse effects and feasibility of the treatment. Participants will have follow-up visits and communications via telephone, in-person, email, or video during the study period. The study includes baseline imaging and lab tests to ensure eligibility and monitor health status throughout the trial.

CONDITIONS

Brief Title

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

Research Team

A

Amanda Kabage

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here